Claims for Patent: 10,982,003

✉ Email this page to a colleague

Summary for Patent: 10,982,003

Title:	Production of proteins in glutamine-free cell culture media
Abstract:	The present invention relates generally to glutamine-free cell culture media supplemented with asparagine. The invention further concerns the production of recombinant proteins, such as antibodies, in asparagine-supplemented glutamine-free mammalian cell culture.
Inventor(s):	Martin Gawlitzek, Shun Luo, Christina Teresa Bevilacqua
Assignee:	Genentech Inc
Application Number:	US16/412,791
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 10,982,003
Patent Claims:

Details for Patent 10,982,003

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	RITUXAN	rituximab	Injection	103705	November 26, 1997	⤷ Start Trial	2039-05-15
Idec Pharmaceuticals Corp.	RITUXAN	rituximab	Injection	103737	February 19, 2002	⤷ Start Trial	2039-05-15
Genentech, Inc.	HERCEPTIN	trastuzumab	For Injection	103792	September 25, 1998	⤷ Start Trial	2039-05-15
Genentech, Inc.	HERCEPTIN	trastuzumab	For Injection	103792	February 10, 2017	⤷ Start Trial	2039-05-15
Genentech, Inc.	AVASTIN	bevacizumab	Injection	125085	February 26, 2004	⤷ Start Trial	2039-05-15
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,982,003

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Africa	201200763	⤷ Start Trial
World Intellectual Property Organization (WIPO)	2011019619	⤷ Start Trial
United States of America	9714293	⤷ Start Trial
United States of America	8512983	⤷ Start Trial
United States of America	2025136705	⤷ Start Trial
United States of America	2025066493	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.